Skip to main content
OpenTrials

Clinical trial condition

Recurrent Adult Brain Tumor

Explore clinical trials studying Recurrent Adult Brain Tumor. Study availability and eligibility vary by location and protocol.

37 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Adult Brain Tumor trial results

Completed

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Recurrent Meningioma

NCT00045734

Conditions
Adult Grade I Meningioma, Adult Grade II Meningioma, Adult Grade III Meningioma, +16 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

NCT00379080

Conditions
Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Pazopanib in Treating Patients With Recurrent Glioblastoma

NCT00459381

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

FR901228 in Treating Patients With Recurrent High-Grade Gliomas

NCT00085540

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00445588

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide

NCT00369590

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

NCT00112736

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, +27 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00093613

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Adult Brain Tumor Consortium Baltimore, Maryland, United States
View Trial Details

Related conditions